Short Interest in Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Declines By 34.4%

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 79,768 shares, a decrease of 34.4% from the April 15th total of 121,549 shares. Based on an average daily volume of 777,518 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are short sold.

Coloplast A/S Stock Up 4.9%

Shares of Coloplast A/S stock opened at $6.43 on Tuesday. The company has a market cap of $14.49 billion, a P/E ratio of 45.93, a PEG ratio of 1.94 and a beta of 0.15. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30. Coloplast A/S has a one year low of $6.10 and a one year high of $10.03. The firm has a fifty day moving average of $6.65 and a two-hundred day moving average of $7.89.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. On average, analysts forecast that Coloplast A/S will post 0.4 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently commented on CLPBY. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.